When the Sjöberg Foundation recently distributed research grants in the area of difficult-to-treat cancer with a poor prognosis, three of the total of nine grants funded went to projects at Sahlgrenska Academy and Sahlgrenska University Hospital. Jonas Nilsson receives SEK 5 million for his project on CAR-T cell treatment for treatment-resistant skin and uveal melanoma. Göran Stenman receives SEK 3 million for the development of a new targeted treatment for patients with the therapy-resistant and deadly cancer form adenoid cystic cancer. Karin Sundfeldt receives SEK 4 million for the development of a screening tool for ovarian cancer that greatly may reduce mortality from the disease.
Sahlgrenska akademins nyheter
Basic research saves lives in children with high-risk neuroblastoma
Nominate Electoral Assembly electors that will appoint teacher representatives to the University Board – by September 1st
Platzer buys buildings on Medicinareberget
Swedish Research Council awards SEK 15 million for follow-up of COVID-19 vaccines
Remembering Lars Hamberger, a pioneer in IVF
Major risk of eye injuries from padel, research ophthalmologists say
Preparations are underway for the herbarium, one of Natrium’s many special features
Agneta Holmäng: We can leverage the positive lessons from remote working
AI.se wants to know your Challenges!
